Company
United StatesRegenesis Pharmaceutical Inc., Santa Ana, CA – FDA Inspections
Inspection records and compliance data for Regenesis Pharmaceutical Inc. in Santa Ana, California. 1 FDA inspection on record, 1 Form 483, last inspected June 18, 2019.
Company Profile
This profile covers Regenesis Pharmaceutical Inc. based in Santa Ana, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected June 18, 2019.
Most cited issue areas
- Calibration/Inspection/Checking not done1 inspection
- Control procedures to monitor and validate performance1 inspection
- Identity Testing of Each Component1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 18, 2019 | VAI | Human Drugs · Unapproved and Misbranded Drugs | 1093423 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Regenesis Pharmaceutical Inc.
FEI Number
3015180086
Address
13081 Rosalind Dr, Santa Ana, California 92705, United States
Country
United States
ID: e74e384c-018e-4735-b2f2-7cf6dd27a8fa